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Clean living staves off 
autoimmunity
 
Autoreactive T cells are harmless until they are 
prodded into action by exposure to common 
microbes, according to Yoshitomi and 
colleagues on page 949. These results may
help explain the contribution of environmental 
factors to human autoimmune diseases like 
rheumatoid arthritis and diabetes.
While studying an arthritis-prone strain of 
mouse, Yoshitomi et al. noted that these mice 
did not develop disease when housed in a 
microbe-free environment, despite the presence 
of T cells that could induce arthritis when 
transferred to nude mice. Only when mice were 
moved to nonsterile conditions (where they 
acquired fungal infections) or were injected 
with 
 
 
 
-glucans from fungal cell walls did the 
telltale symptoms of arthritis appear. Treatment 
of the mice with antifungal drugs or antibodies 
that blocked binding of 
 
 
 
-glucans to cells 
reversed this effect, suggesting a direct link 
between exposure to fungi and development 
of disease.
The same fungal products that triggered 
arthritis stimulated dendritic cells (DCs), the cells 
responsible for activating T cells, to upregulate 
costimulatory molecules and secrete cytokines. 
The authors suspect that 
 
 
 
-glucans, detectable 
in the circulation during infection, reach the local 
lymph nodes where they prompt DCs to activate 
autoreactive T cells. Once activated, the T cells 
invade the joints. The group now plans to 
investigate possible defects in regulatory T cells
in this model, as these cells normally keep 
autoreactive T cells in check.
Fungal infections trigger arthritis in susceptible SKG 
mice (arrowheads indicate fungal spores in the lung).
 
Too old to help
 
Old mice have reduced CD4
 
 
 
 T cell function but, according to new data
from Haynes and colleagues (page 845), the elderly environment is not
to blame. Newly generated T cells functioned normally in elderly mice,
suggesting that strategies to boost T cell production might be an effective
way to improve vaccine efficacy in the elderly.
Previous work by this group has shown that age-related defects
in antibody production result from declining CD4
 
 
 
 T cell help, not
from faulty B cells. By depleting the existing pool of CD4
 
 
 
 T cells
and forcing the thymus to churn out a fresh supply, the authors show
that newly generated CD4
 
 
 
 T cells are equally responsive to antigen
whether they are produced in a young or an old mouse. This suggests
that their functional demise depended on the age of the individual T
cell, not on the age of the mouse.
Although there were no detectable phenotypic differences between old
and young T cells, the authors postulate that unknown defects accumulate
in T cells as they divide and age in the periphery. In young mice, the new
T cells produced by the thymus compensate for the reduced function of their
elderly predecessors. But thymic output decreases with age, and eventually
old T cells outnumber young ones, causing overall T cell function to decline.
Production of B cells, by contrast, does not decrease as drastically with age,
which may explain why B cells are more resistant to the effects of aging.
Although the nature of the defects that accumulate in aging T cells are
not known, recent studies showing an age-related decrease in immune
synapse formation between T cells and antigen presenting cells point to
potential alterations in plasma membrane components. Haynes suggests
that changes in the lipid composition of the plasma membrane—possibly
resulting from routine oxidative stress—may make the membranes less
fluid and slow down the movement of key signaling molecules into the
immune synapse.
CD4  T cells accumulate functional defects as they age. (T cell image provided by 
Michael Dustin, New York University, NY, NY.)
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